Invesco Ltd. Vbi Vaccines Inc Transaction History

Invesco Ltd.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.29 - $0.64 $1,281 - $2,828	-4,419 Reduced 8.03%	50,625 $15,000
Q4 2022 Feb 13, 2023	SELL	$0.38 - $22.5 $310,245 - $18.4 Million	-816,435 Reduced 93.68%	55,044 $21,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $23.4 $141,362 - $4.53 Million	193,647 Added 28.57%	871,479 $615,000
Q2 2022 Aug 15, 2022	BUY	$0.66 - $1.81 $130,724 - $358,501	198,067 Added 41.28%	677,832 $548,000
Q1 2022 May 16, 2022	BUY	$1.27 - $2.47 $121,168 - $235,657	95,408 Added 24.82%	479,765 $797,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $177,297 - $258,324	80,225 Added 26.38%	384,357 $900,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $89,591 - $119,028	31,997 Added 11.76%	304,132 $946,000
Q2 2021 Aug 17, 2021	SELL	$2.61 - $4.17 $56,558 - $90,363	-21,670 Reduced 7.38%	272,135 $913,000
Q1 2021 May 17, 2021	BUY	$2.91 - $4.32 $110,015 - $163,321	37,806 Added 14.77%	293,805 $914,000
Q4 2020 Feb 16, 2021	BUY	$2.15 - $3.5 $78,631 - $128,005	36,573 Added 16.67%	255,999 $704,000
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $451,507 - $1.01 Million	162,999 Added 288.87%	219,426 $628,000
Q2 2020 Aug 14, 2020	BUY	$0.87 - $3.13 $49,091 - $176,616	56,427 New	56,427 $175,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.